Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Co-Diagnostics (CODX) Announces Closing of $4.2 Million Registered Direct Offering Priced At-the-Market
-
Co-Diagnostics Announces Closing of $4.2 Million Registered Direct Offering Priced At-the-Market
-
NLS Pharmaceutics Ltd. (NLS) Files Registration Statement for a Proposed Initial Public Offering
-
Biocept (BIOC) Prices 23M Share Registered Direct Offering at $0.40/Sh
-
Biocept Announces Pricing of $9.2 Million Registered Direct Offering Priced At-The-Market
-
Aptorum Group Announces Closing of $10 Million Registered Direct Offering of Class A Ordinary Shares and Warrants
-
Lianluo Smart Limited (LLIT) Prices 4.9M Class A Share Offering at $0.70/Sh
-
Lianluo Smart Limited Announces Pricing of Approximately $3.4 Million Offering
-
Co-Diagnostics (CODX) Announces $4.2 Million Registered Direct Offering Priced At-the-Market
-
Co-Diagnostics Announces $4.2 Million Registered Direct Offering Priced At-the-Market
-
Aptorum Group Limited (APM) Prices $10 Million Registered Direct Offering of Ordinary Shares and Warrants
-
Aptorum Group Announces Pricing of $10 Million Registered Direct Offering
-
ContraFect Corp. (CFRX) PT Raised to $22 at Maxim Group
-
Adamis Pharmaceuticals (ADMP) Prices $6.7M Registered Direct Offering
-
Adamis Pharmaceuticals Announces Pricing of $6.7 Million Registered Direct Offering
-
Agile Therapeutics (AGRX) Prices 15M Share Offering at $3/Sh
-
UPDATE: Lianluo Smart Limited (LLIT) Prices 3.5M Class A Share Offering at $0.70/Sh
-
Agile Therapeutics Announces Pricing of $45 Million Underwritten Public Offering of Common Stock
-
Agile Therapeutics Announces Pricing of $45 Million Underwritten Public Offering of Common Stock
-
Lianluo Smart Limited Announces Pricing of Approximately $2.5 Million Offering
-
Priority Income Fund, Inc. Prices Offering of Preferred Stock
-
Priority Income Fund, Inc. Prices Offering of Preferred Stock
-
Agile Therapeutics (AGRX) to Offer Common Stock
-
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
-
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
-
Maxim Group Starts Aptose Biosciences (APTO) at Buy
-
Priority Income Fund, Inc. Launches Preferred Stock Offering
-
Priority Income Fund, Inc. Launches Preferred Stock Offering
-
Euroseas Ltd. (ESEA) PT Lowered to $5 at Maxim Group, Following Earnings
-
Medalist Diversified REIT Closes $4.6 Million Underwritten Public Offering of Series A Preferred Stock
-
Yunhong International Announces Closing of Upsized $60 Million Initial Public Offering
-
Aridis Pharmaceuticals to Host Investor Day Showcasing APEX™ Technology Platform and Key Opinion Leader Panels on Cystic Fibrosis and Pneumonia
-
Churchill Capital Corp III Announces Pricing of $1 Billion Initial Public Offering
-
EuroDry Ltd. (EDRY) PT Lowered to $8 at Maxim Group, Following Earnings
-
UPDATE: Zosano Pharma (ZSAN) PT Lowered to $2 at Maxim Group, On Recent Dilution
-
Yunhong International (ZGYHU) IPO Opens Flat
-
Medalist Diversified REIT Prices $4.6 Million Underwritten Public Offering of Series A Preferred Stock
-
Yunhong International Announces Pricing of Upsized $60 Million Initial Public Offering
-
Turtle Beach Corporation (HEAR) PT Lowered to $16 at Maxim Group
-
Lianluo Smart Limited (LLIT) Prices 2.8M Class A Share Offering at $0.85/Sh
-
Lianluo Smart Limited Announces Pricing of Approximately $2.2 Million Offering
-
Amplitech Group, Inc. Files Roadshow Presentation Ahead of Launch on M-Vest.com and Maxim Investor Meetings
-
Amplitech Group, Inc. Files Roadshow Presentation Ahead of Launch on M-Vest.com and Maxim Investor Meetings
-
Dunkin' Brands (DNKN) PT Lowered to $81 at Maxim Group, Following Earnings
-
UPDATE: Moleculin Biotech (MBRX) Announces $6M Registered Direct Offering at $0.80/Unit
-
Moleculin Announces $6.0 Million Registered Direct Offering
-
Maxim Group Starts Heat Biologics (HTBX) at Buy
-
Maxim Group Starts Armata Pharmaceuticals (ARMP) at Buy
-
Maxim Group Starts Toughbuilt Industries Inc. (TBLT) at Buy
-
SINTX TECHNOLOGIES ANNOUNCES EXPIRATION OF OVERSUBSCRIBED RIGHTS OFFERING

